These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

227 related items for PubMed ID: 35305632

  • 1. Epidemiology, healthcare utilization, and related costs among patients with IPF: results from a German claims database analysis.
    Kreuter M, Picker N, Schwarzkopf L, Baumann S, Cerani A, Postema R, Maywald U, Dittmar A, Langley J, Patel H.
    Respir Res; 2022 Mar 19; 23(1):62. PubMed ID: 35305632
    [Abstract] [Full Text] [Related]

  • 2. Patterns and Economic Burden of Hospitalizations and Exacerbations Among Patients Diagnosed with Idiopathic Pulmonary Fibrosis.
    Yu YF, Wu N, Chuang CC, Wang R, Pan X, Benjamin NN, Devercelli G, Coultas DB.
    J Manag Care Spec Pharm; 2016 Apr 19; 22(4):414-23. PubMed ID: 27023695
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Real-world antifibrotic treatment patterns in patients with idiopathic pulmonary fibrosis: retrospective analyses of two large healthcare administrative databases in the United States.
    Qiu Y, Zhu J, Chopra P, Elpers B, Dieyi C, Byrne C, Tang J, Wang Y, Govindaraj K, Fischer A.
    Ther Adv Respir Dis; 2024 Apr 19; 18():17534666241280704. PubMed ID: 39418137
    [Abstract] [Full Text] [Related]

  • 6. Health care utilization and costs of idiopathic pulmonary fibrosis in U.S. Medicare beneficiaries aged 65 years and older.
    Collard HR, Chen SY, Yeh WS, Li Q, Lee YC, Wang A, Raghu G.
    Ann Am Thorac Soc; 2015 Jul 19; 12(7):981-7. PubMed ID: 25923447
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Health Care Costs at the End of Life for Patients with Idiopathic Pulmonary Fibrosis. Evaluation of a Pilot Multidisciplinary Collaborative Interstitial Lung Disease Clinic.
    Kalluri M, Lu-Song J, Younus S, Nabipoor M, Richman-Eisenstat J, Ohinmaa A, Bakal JA.
    Ann Am Thorac Soc; 2020 Jun 19; 17(6):706-713. PubMed ID: 32197048
    [Abstract] [Full Text] [Related]

  • 10. Claims-based Prevalence of Disease Progression among Patients with Fibrosing Interstitial Lung Disease Other than Idiopathic Pulmonary Fibrosis in the United States.
    Singer D, Bengtson LGS, Conoscenti CS, Laouri M, Shetty SS, Anderson AJ, Brown KK.
    Ann Am Thorac Soc; 2022 Jul 19; 19(7):1112-1121. PubMed ID: 35015982
    [Abstract] [Full Text] [Related]

  • 11. Hospital-Based Resource Use and Costs Among Patients With Idiopathic Pulmonary Fibrosis Enrolled in the Idiopathic Pulmonary Fibrosis Prospective Outcomes (IPF-PRO) Registry.
    Fan Y, Bender SD, Conoscenti CS, Davidson-Ray L, Cowper PA, Palmer SM, de Andrade JA, IPF-PRO Registry Investigators.
    Chest; 2020 Jun 19; 157(6):1522-1530. PubMed ID: 32004554
    [Abstract] [Full Text] [Related]

  • 12. Burden of illness in progressive fibrosing interstitial lung disease.
    Singer D, Bengtson LGS, Conoscenti CS, Anderson AJ, Brekke L, Shetty SS, Brown KK.
    J Manag Care Spec Pharm; 2022 Aug 19; 28(8):871-880. PubMed ID: 35876293
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Healthcare Resource Utilization and Related Costs in Chronic Fibrosing Interstitial Lung Diseases with a Progressive Phenotype: A US Claims Database Analysis.
    Olson AL, Hartmann N, Patnaik P, Garry EM, Bohn RL, Singer D, Baldwin M, Wallace L.
    Adv Ther; 2022 Apr 19; 39(4):1794-1809. PubMed ID: 35199282
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Hospital cost and length of stay in idiopathic pulmonary fibrosis.
    Mooney JJ, Raimundo K, Chang E, Broder MS.
    J Med Econ; 2017 May 19; 20(5):518-524. PubMed ID: 28092235
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Prevalence and Incidence of Chronic Fibrosing Interstitial Lung Diseases with a Progressive Phenotype in the United States Estimated in a Large Claims Database Analysis.
    Olson AL, Patnaik P, Hartmann N, Bohn RL, Garry EM, Wallace L.
    Adv Ther; 2021 Jul 19; 38(7):4100-4114. PubMed ID: 34156606
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.